Patents

  1. US Patent No: US9872868B2: Mitochondrially-Targeted Electrophilic Compounds and Methods of Use for the Treatment of Cancer, Aimee Landar and Sadanandan E. Velu, Date of issue: January 23, 2018.

  2. US Patent No: US6861448: NAD synthetase inhibitors and uses thereof, Wayne J. Brouillette, Lawrence J. DeLucas, Christie Brouillette, Sadanandan E. Velu, Yong-Chul Kim, Liyuan Mou and Stephen R. Porter, Date of issue: March 01, 2005.

  3. European Patent No: EP1578898: NAD synthetase inhibitors and uses thereof, Wayne J. Brouillette;  Lawrence J. DeLucas; Christie G. Brouillette; Sadanandan E. Velu, Yong-Chul Kim, Liyuan Mou and Stephen R. Porter - (Virtual Drug Development, Inc.; The UAB Research Foundation), September 2005.

  4. US Patent No: US6727237: Inhibitors of bacterial NAD synthetase, Wayne J. Brouillette; Donald Muccio; Mark J. Jedrzejas; Christie G. Brouillette; Yancho Devedjiev; Walter Cristofoli; Lawrence J. DeLucas; Gabriel Garcia; Laurent Schmitt; Sadanandan E. Velu, Date of issue: April 27, 2004.

  5. US Patent No: US6500852B1: Inhibitors of bacterial NAD synthetase, Wayne J. Brouillette, Donald Muccio, Mark J. Jedrzejas, Christie Brouillette, Yancho Devedjiev, Walter Cristofoli, Lawrence J. DeLucas, Gabriel Garcia, Laurent Schmitt and Sadanandan E. Velu,  Date of issue: Dec 31, 2002.

  6. European Patent No: EP1109805: Inhibitors of bacterial NAD synthetase, Wayne J. Brouillette, Donald Muccio, Mark J. Jedrzejas, Christie Brouillette, Yancho Devedjiev, Walter Cristofoli, Lawrence J. DeLucas, Gabriel Garcia, Laurent Schmitt and Sadanandan E. Velu, (The UAB Research Foundation),  June 2001.

The Science & 

Mathematics University

  • Facebook Clean Grey
  • Twitter Clean Grey
  • LinkedIn Clean Grey